Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort.

Mukherjee A, Russell R, Chin SF, Liu B, Rueda OM, Ali HR, Turashvili G, Mahler-Araujo B, Ellis IO, Aparicio S, Caldas C, Provenzano E.

NPJ Breast Cancer. 2018 Mar 7;4:5. doi: 10.1038/s41523-018-0056-8. eCollection 2018.

2.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RAEM, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, Investigators K, Bolla MK, Wang Q, Jones ME, Schoemaker MJ, Keeman R, Easton DF, Swerdlow AJ, Sherman ME, Schmidt MK, Pharoah PD, Garcia-Closas M.

Int J Cancer. 2018 Aug 15;143(4):746-757. doi: 10.1002/ijc.31352. Epub 2018 Mar 25.

3.

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.

Álvarez-Fernández M, Sanz-Flores M, Sanz-Castillo B, Salazar-Roa M, Partida D, Zapatero-Solana E, Ali HR, Manchado E, Lowe S, VanArsdale T, Shields D, Caldas C, Quintela-Fandino M, Malumbres M.

Cell Death Differ. 2018 May;25(5):828-840. doi: 10.1038/s41418-017-0024-0. Epub 2017 Dec 11.

4.

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.

James FR, Jiminez-Linan M, Alsop J, Mack M, Song H, Brenton JD, Pharoah PDP, Ali HR.

BMC Cancer. 2017 Sep 20;17(1):657. doi: 10.1186/s12885-017-3585-x.

5.

A rapid Fourier transform infrared spectroscopic method for analysis of certain proton pump inhibitors in binary and ternary mixtures.

Khashaba PY, Ali HRH, El-Wekil MM.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Feb 5;190:10-14. doi: 10.1016/j.saa.2017.09.003. Epub 2017 Sep 5.

PMID:
28889052
6.

Development of a novel and cost-effective redox sensor for voltammetric determination of pantoprazole sodium during pharmacokinetic studies.

Khashaba PY, Ali HRH, El-Wekil MM.

R Soc Open Sci. 2017 Aug 9;4(8):170324. doi: 10.1098/rsos.170324. eCollection 2017 Aug.

7.

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.

Ali HR, Dariush A, Thomas J, Provenzano E, Dunn J, Hiller L, Vallier AL, Abraham J, Piper T, Bartlett JMS, Cameron DA, Hayward L, Brenton JD, Pharoah PDP, Irwin MJ, Walton NA, Earl HM, Caldas C.

Ann Oncol. 2017 Aug 1;28(8):1832-1835. doi: 10.1093/annonc/mdx266.

8.

Simultaneous voltammetric analysis of anti-ulcer and D2-antagonist agents in binary mixture using redox sensor and their determination in human serum.

Khashaba PY, Ali HRH, El-Wekil MM.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:733-741. doi: 10.1016/j.msec.2017.02.092. Epub 2017 Feb 24.

PMID:
28415523
9.

Novel polyacrylamide-based solid scale inhibitor.

Younes AA, El-Maghrabi HH, Ali HR.

J Hazard Mater. 2017 Jul 15;334:1-9. doi: 10.1016/j.jhazmat.2017.03.052. Epub 2017 Mar 29.

PMID:
28384554
10.

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, Aittomäki K, Liu J, Ali HR, Andrulis IL, Beckmann MW, Behrens S, Blows FM, Brenner H, Chang-Claude J, Couch FJ, Czene K, Fasching PA, Figueroa J, Floris G, Glendon G, Guo Q, Hall P, Hallberg E, Hamann U, Holleczek B, Hooning MJ, Hopper JL, Jager A, Kabisch M; kConFab/AOCS Investigators, Keeman R, Kosma VM, Lambrechts D, Lindblom A, Mannermaa A, Margolin S, Provenzano E, Shah M, Southey MC, Dennis J, Lush M, Michailidou K, Wang Q, Bolla MK, Dunning AM, Easton DF, Pharoah PD, Chenevix-Trench G, Blomqvist C, Nevanlinna H.

Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.

11.

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

van de Ven RA, de Groot JS, Park D, van Domselaar R, de Jong D, Szuhai K, van der Wall E, Rueda OM, Ali HR, Caldas C, van Diest PJ, Hetzer MW, Sahai E, Derksen PW.

Nat Commun. 2016 Dec 22;7:13874. doi: 10.1038/ncomms13874.

12.

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Ali HR, Chlon L, Pharoah PD, Markowetz F, Caldas C.

PLoS Med. 2016 Dec 13;13(12):e1002194. doi: 10.1371/journal.pmed.1002194. eCollection 2016 Dec.

13.

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

Abubakar M, Orr N, Daley F, Coulson P, Ali HR, Blows F, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RA, Seynaeve C, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, Investigators K, Bolla MK, Wang Q, Jones M, Schoemaker M, Wesseling J, van Leeuwen FE, Van 't Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M.

Breast Cancer Res. 2016 Oct 18;18(1):104.

14.

Gold Nanorods as Drug Delivery Vehicles for Rifampicin Greatly Improve the Efficacy of Combating Mycobacterium tuberculosis with Good Biocompatibility with the Host Cells.

Ali HR, Ali MR, Wu Y, Selim SA, Abdelaal HF, Nasr EA, El-Sayed MA.

Bioconjug Chem. 2016 Oct 19;27(10):2486-2492. Epub 2016 Sep 22.

PMID:
27595304
15.

Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis.

Ali MR, Ibrahim IM, Ali HR, Selim SA, El-Sayed MA.

Int J Nanomedicine. 2016 Sep 22;11:4849-4863. eCollection 2016.

16.

Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy.

Ali MR, Ali HR, Rankin CR, El-Sayed MA.

Biomaterials. 2016 Sep;102:1-8. doi: 10.1016/j.biomaterials.2016.06.017. Epub 2016 Jun 7.

PMID:
27318931
17.

Occurrence and distribution of antifouling biocide Irgarol-1051 in coral reef ecosystems, Zanzibar.

Sheikh MA, Juma FS, Staehr P, Dahl K, Rashid RJ, Mohammed MS, Ussi AM, Ali HR.

Mar Pollut Bull. 2016 Aug 15;109(1):586-590. doi: 10.1016/j.marpolbul.2016.05.035. Epub 2016 May 24.

PMID:
27234364
18.

The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.

Mendoza-Villanueva D, Balamurugan K, Ali HR, Kim SR, Sharan S, Johnson RC, Merchant AS, Caldas C, Landberg G, Sterneck E.

Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.

19.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Ali HR, Dariush A, Provenzano E, Bardwell H, Abraham JE, Iddawela M, Vallier AL, Hiller L, Dunn JA, Bowden SJ, Hickish T, McAdam K, Houston S, Irwin MJ, Pharoah PD, Brenton JD, Walton NA, Earl HM, Caldas C.

Breast Cancer Res. 2016 Feb 16;18(1):21. doi: 10.1186/s13058-016-0682-8.

20.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR, Gaber A, O'Hurley G, Lehn S, Muris JJ, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O'Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Sci Rep. 2016 Jan 5;6:18517. doi: 10.1038/srep18517.

21.

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.

Sung H, Garcia-Closas M, Chang-Claude J, Blows FM, Ali HR, Figueroa J, Nevanlinna H, Fagerholm R, Heikkilä P, Blomqvist C, Giles GG, Milne RL, Southey MC, McLean C, Mannermaa A, Kosma VM, Kataja V, Sironen R, Couch FJ, Olson JE, Hallberg E, Olswold C, Cox A, Cross SS, Kraft P, Tamimi RM, Eliassen AH, Schmidt MK, Bolla MK, Wang Q, Easton D, Howat WJ, Coulson P, Pharoah PD, Sherman ME, Yang XR.

Br J Cancer. 2016 Feb 2;114(3):298-304. doi: 10.1038/bjc.2015.437. Epub 2015 Dec 17.

22.

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, Kingsbury Z, Humphray S, Bentley D, Shah SP, Wallis M, Rosenfeld N, Caldas C.

Nat Commun. 2015 Nov 4;6:8760. doi: 10.1038/ncomms9760.

23.

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.

Candido Dos Reis FJ, Lynn S, Ali HR, Eccles D, Hanby A, Provenzano E, Caldas C, Howat WJ, McDuffus LA, Liu B, Daley F, Coulson P, Vyas RJ, Harris LM, Owens JM, Carton AF, McQuillan JP, Paterson AM, Hirji Z, Christie SK, Holmes AR, Schmidt MK, Garcia-Closas M, Easton DF, Bolla MK, Wang Q, Benitez J, Milne RL, Mannermaa A, Couch F, Devilee P, Tollenaar RA, Seynaeve C, Cox A, Cross SS, Blows FM, Sanders J, de Groot R, Figueroa J, Sherman M, Hooning M, Brenner H, Holleczek B, Stegmaier C, Lintott C, Pharoah PD.

EBioMedicine. 2015 May 9;2(7):681-9. doi: 10.1016/j.ebiom.2015.05.009. eCollection 2015 Jul.

24.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM, Coulson P, Patrycja G, Schellens JH, Fagerholm R, Heikkilä P, Aittomäki K, Blomqvist C, Provenzano E, Ali HR, Figueroa J, Sherman M, Lissowska J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Phillips KA; kConFab/AOCS Investigators, Couch FJ, Olson JE, Vachon C, Visscher D, Brenner H, Butterbach K, Arndt V, Holleczek B, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, van de Water B, Broeks A, Chang-Claude J, Chenevix-Trench G, Easton DF, Pharoah PD, García-Closas M, de Graauw M, Schmidt MK.

BMC Med. 2015 Jul 2;13:156. doi: 10.1186/s12916-015-0392-6.

25.

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.

Blows FM, Ali HR, Dawson SJ, Le Quesne J, Provenzano E, Caldas C, Pharoah PD.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):221-6. doi: 10.1097/PAI.0000000000000172. Erratum in: Appl Immunohistochem Mol Morphol. 2016 May-Jun;24(5):382.

26.

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.

Ali HR, Glont SE, Blows FM, Provenzano E, Dawson SJ, Liu B, Hiller L, Dunn J, Poole CJ, Bowden S, Earl HM, Pharoah PD, Caldas C.

Ann Oncol. 2015 Jul;26(7):1488-93. doi: 10.1093/annonc/mdv192. Epub 2015 Apr 20.

PMID:
25897014
27.

Prognostic and predictive value of PDL1 expression in breast cancer.

Sabatier R, Finetti P, Mamessier E, Adelaide J, Chaffanet M, Ali HR, Viens P, Caldas C, Birnbaum D, Bertucci F.

Oncotarget. 2015 Mar 10;6(7):5449-64.

28.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M.

J Pathol Clin Res. 2014 Dec 4;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan.

29.

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer.

Wishart GC, Rakha E, Green A, Ellis I, Ali HR, Provenzano E, Blows FM, Caldas C, Pharoah PD.

BMC Cancer. 2014 Dec 3;14:908. doi: 10.1186/1471-2407-14-908.

30.

Genome-driven integrated classification of breast cancer validated in over 7,500 samples.

Ali HR, Rueda OM, Chin SF, Curtis C, Dunning MJ, Aparicio SA, Caldas C.

Genome Biol. 2014 Aug 28;15(8):431. doi: 10.1186/s13059-014-0431-1.

31.

Contamination of diuron in coastal waters around Malaysian Peninsular.

Ali HR, Arifin MM, Sheikh MA, Shazili NA, Bakari SS, Bachok Z.

Mar Pollut Bull. 2014 Aug 15;85(1):287-91. doi: 10.1016/j.marpolbul.2014.05.049. Epub 2014 Jun 13.

PMID:
24934440
32.

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.

Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, Earl HM, Poole CJ, Hiller L, Dunn JA, Bowden SJ, Twelves C, Bartlett JM, Mahmoud SM, Rakha E, Ellis IO, Liu S, Gao D, Nielsen TO, Pharoah PD, Caldas C.

Ann Oncol. 2014 Aug;25(8):1536-43. doi: 10.1093/annonc/mdu191. Epub 2014 Jun 9.

PMID:
24915873
33.

Micellar electrokinetic chromatographic determination of rosuvastatin in rabbit plasma and evaluation of its pharmacokinetics and interaction with niacin.

El-Kommos ME, Mohamed NA, Ali HR, Abdel Hakiem AF.

Biomed Chromatogr. 2014 Dec;28(12):1828-38. doi: 10.1002/bmc.3227. Epub 2014 May 14.

PMID:
24828212
34.

Occurrence and distribution of antifouling biocide Irgarol-1051 in coastal waters of Peninsular Malaysia.

Ali HR, Arifin MM, Sheikh MA, Mohamed Shazili NA, Bachok Z.

Mar Pollut Bull. 2013 May 15;70(1-2):253-7. doi: 10.1016/j.marpolbul.2013.02.024. Epub 2013 Mar 11.

PMID:
23490347
35.

Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.

Mohammed H, D'Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, Stingl J, Palmieri C, Caldas C, Carroll JS.

Cell Rep. 2013 Feb 21;3(2):342-9. doi: 10.1016/j.celrep.2013.01.010. Epub 2013 Feb 9.

36.

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.

Ali HR, Irwin M, Morris L, Dawson SJ, Blows FM, Provenzano E, Mahler-Araujo B, Pharoah PD, Walton NA, Brenton JD, Caldas C.

Br J Cancer. 2013 Feb 19;108(3):602-12. doi: 10.1038/bjc.2012.558. Epub 2013 Jan 17.

37.

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.

Yuan Y, Failmezger H, Rueda OM, Ali HR, Gräf S, Chin SF, Schwarz RF, Curtis C, Dunning MJ, Bardwell H, Johnson N, Doyle S, Turashvili G, Provenzano E, Aparicio S, Caldas C, Markowetz F.

Sci Transl Med. 2012 Oct 24;4(157):157ra143. doi: 10.1126/scitranslmed.3004330. Erratum in: Sci Transl Med. 2012 Oct 24;4(157):161er6.

38.

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C.

Br J Cancer. 2012 May 22;106(11):1798-806. doi: 10.1038/bjc.2012.167. Epub 2012 Apr 26.

39.

Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin.

Ali HR, Alhalaweh A, Velaga SP.

Drug Dev Ind Pharm. 2013 May;39(5):625-34. doi: 10.3109/03639045.2012.671831. Epub 2012 Apr 5.

PMID:
22480325
40.

Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.

Quesne JL, Jones J, Warren J, Dawson SJ, Ali HR, Bardwell H, Blows F, Pharoah P, Caldas C.

J Pathol. 2012 Jul;227(3):306-14. doi: 10.1002/path.3983. Epub 2012 May 8.

PMID:
22294324
41.

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS.

Nature. 2012 Jan 4;481(7381):389-93. doi: 10.1038/nature10730.

42.

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C.

Breast Cancer Res. 2011;13(6):R118. doi: 10.1186/bcr3061. Epub 2011 Nov 23.

43.

A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Leung S, Nielsen T, Pharoah PD, Caldas C.

J Pathol. 2012 Jan;226(1):97-107. doi: 10.1002/path.2976. Epub 2011 Sep 26.

PMID:
21953021
44.

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.

Holland DG, Burleigh A, Git A, Goldgraben MA, Perez-Mancera PA, Chin SF, Hurtado A, Bruna A, Ali HR, Greenwood W, Dunning MJ, Samarajiwa S, Menon S, Rueda OM, Lynch AG, McKinney S, Ellis IO, Eaves CJ, Carroll JS, Curtis C, Aparicio S, Caldas C.

EMBO Mol Med. 2011 Mar;3(3):167-80. doi: 10.1002/emmm.201100122. Epub 2011 Feb 18.

45.

An experimental and computational study on the epimeric contribution to the infrared spectrum of budesonide.

Ali HR, Edwards HG, Kendrick J, Munshi T, Scowen IJ.

Drug Test Anal. 2010 Sep;2(9):447-51. doi: 10.1002/dta.152.

PMID:
20812265
46.

Non-invasive in situ identification and band assignments of diazepam, flunitrazepam and methadone hydrochloride with FT-near-infrared spectroscopy.

Ali HR.

Forensic Sci Int. 2011 Mar 20;206(1-3):87-91. doi: 10.1016/j.forsciint.2010.06.029. Epub 2010 Jul 24.

PMID:
20656427
47.

Computational and vibrational spectroscopic studies of ipratropium bromide.

Ali HR, Edwards HG, Kendrick J, Scowen IJ.

Drug Test Anal. 2009 Feb;1(2):73-80. doi: 10.1002/dta.17.

PMID:
20355179
48.

Noninvasive in situ identification and band assignments of some pharmaceutical excipients inside USP vials with FT-near-infrared spectroscopy.

Ali HR, Edwards HG, Scowen IJ.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 May;72(4):890-6. doi: 10.1016/j.saa.2008.12.010. Epub 2008 Dec 24.

PMID:
19153058
49.

Vibrational spectroscopic study of terbutaline hemisulphate.

Ali HR, Edwards HG, Kendrick J, Scowen IJ.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 May;72(4):715-9. doi: 10.1016/j.saa.2008.11.003. Epub 2008 Nov 17.

PMID:
19124270
50.

Vibrational spectroscopic study of salbutamol hemisulphate.

Ali HR, Edwards HG, Kendrick J, Scowen IJ.

Drug Test Anal. 2009 Jan;1(1):51-6. doi: 10.1002/dta.8.

PMID:
20355159

Supplemental Content

Support Center